QA: Cingulate Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001862150_2022_Cingulate_Inc.pdf

Logs

warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001862150', 'EntityCommonStockSharesOutstanding': 11309412, 'Assets': 22886257, 'AssetsCurrent': 18882279, 'ComprehensiveNetIncome': -20709991, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 2042715, 'LiabilitiesAndStockholdersEquity': 22886257, 'LiabilitiesCurrent': 1176678, 'LiabilitiesNoncurrent': 828503, 'NetIncome': -20709991, 'PropertyPlantAndEquipmentNet': 3145378, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 858600, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 37534, 'remainder_LiabilitiesAndStockholdersEquity': 20843542, 'remainder_NetIncome': -20709991, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001862150')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Edgar->Model Mapping